Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (May 29, 2003)

Reports
Other Events
Filing Date
Filed May 29, 2003
Period End
May 29, 2003
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed May 29, 2003. Cited figures are marked; the original filing is the authoritative source.

Procter & Gamble's May 29, 2003 Form 8-K, filed under Regulation FD, reports that the initial acceptance period for P&G's tender offer for Wella AG expired on May 28, 2003.

Preliminary results showed 5,042,259 voting shares (11.42%a of that class) and 1,451,583 preference shares (6.21%) tendered, or 9.62% of Wella's registered share capital. The filing is a disclosure of deal progress rather than a new financial result, so it carries no earnings, revenue, or balance sheet figures. P&G already holds majority control of Wella through a March 17, 2003 share purchase agreement covering 77.6% of Wella's voting shares from its majority shareholders.

The company states it will not raise the offer price regardless of how many additional shares are tendered. Under German law, a mandatory two-week additional acceptance period runs from June 6 to June 20, 2003, with final initial-period results due June 5. Management said it expects most of the remaining tenders to arrive late in that window.

For investors, the key takeaways are that P&G's control of Wella does not depend on the tender outcome, that the offer price is fixed, and that P&G does not need a domination agreement to pursue its planned integration. Completion remains subject to regulatory approvals, including in the European Union and the United States. The filing also repeats forward-looking-statement risks, including integration execution, emerging-market growth, currency and commodity exposure, and Latin American political and economic uncertainty.

Key Highlights

  1. Initial Wella tender offer acceptance period expired May 28, 2003; preliminary tenders were 9.62% of Wella's registered share capital (11.42% of voting shares, 6.21% of preference shares).
  2. P&G already controls Wella via a March 17, 2003 agreement to buy 77.6% of voting shares from majority holders, so control does not depend on the tender result.
  3. Offer prices are fixed: EUR 92.25 per voting share and EUR 65.00 per preference share, with management stating no price increase regardless of tender levels.
  4. Mandatory additional acceptance period runs June 6 to June 20, 2003; final initial-period results are due June 5, 2003.
  5. The offer price was described as fair by Wella's Executive Board, which said its members would tender their shares, though the board gave no formal opinion to shareholders.
  6. P&G states it does not need a domination agreement to achieve its financial objectives and will implement its business plans once the deal closes.
  7. Closing remains subject to regulatory review and approvals, including in the European Union and the United States.

Frequently Asked Questions

  1. Did P&G report any financial results in this 8-K?

    No. The filing is a Regulation FD disclosure about the tender offer's initial acceptance period. It contains no earnings, revenue, or balance sheet data.

  2. Does P&G need to acquire more Wella shares to gain control?

    Not according to the company. P&G says it already has majority control through its share purchase agreement with Wella's majority shareholders. It states it is under no obligation to acquire additional shares beyond June 20, 2003.

  3. Will P&G raise its tender offer price if fewer shares are tendered?

    No. Management said it has no intention of increasing the share price irrespective of the number of shares tendered, and German law requires the offer price to stay the same during the additional acceptance period.

  4. What are the next key dates for the Wella tender offer?

    Final results of the initial acceptance period are due June 5, 2003. The mandatory additional two-week acceptance period runs from June 6 to June 20, 2003. Completion also depends on regulatory approvals in markets including the EU and the US.

  5. What premium did P&G offer Wella shareholders?

    For voting shares, the EUR 92.25 offer price represents a 44% premium over the 3-month average before the tender offer announcement. For preference shares, the EUR 65.00 offer price is a 55% premium over the October 11, 2002 pre-merger speculation price and a 14% premium over the 3-month average.